RARA CRAFT DATABASE for FDA Medical Devices
PMAP230023

FDA DEVICE FACTS

GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis

W. L. Gore & Associates, Inc.

Verified FDA Record identity for medical-device development research. This overview uses only fields stated in the FDA Record and is not a Device Description.医療機器開発の調査用に、確認済みの FDA Record の識別情報を示しています。この概要は FDA Record に記載された項目だけによるもので、機器説明ではありません。

DECISION DATEJanuary 12, 2024PRODUCT CODEQZK

Indications for use

The GORE ® EXCLUDER® Thoracoabdominal Branch Endoprosthesis is indicated for endovascular repair in patients with thoracoabdominal aortic aneurysms and high-surgical risk patients with pararenal aortic aneurysms who have appropriate anatomy as described below: 1. Adequate iliac / femoral access and brachial / axillary access 2. Proximal (supraceliac) aortic neck treatment diameter range over 2 cm seal zone of 22 - 34 mm for aneurysms extending up to 6.5 cm or less above the origin of the most proximal branch vessel 3. Aortic neck angle ” 60° at the Aortic Component proximal seal zone 4. Iliac artery treatment diameter range of 8 - 25 mm and iliac artery seal zone length of at least 10 mm 5. Renal artery seal zone diameters between 4.0 - 10.0 mm 6. Celiac and superior mesenteric artery seal zone diameters between 5.0 - 12.0 mm 7. • 15 mm seal zone length in renal arteries, superior mesenteric artery, and celiac artery 8. Visceral segment of aorta (3 cm proximal through 9.5 cm distal to the most proximal visceral artery) must be • 20 mm in diameter

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: September 2, 2026